1EJQ

SOLUTION STRUCTURE OF THE SYNDECAN-4 WHOLE CYTOPLASMIC DOMAIN IN THE PRESENCE OF PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE

SOLUTION NMR

NMR Experiment
Experiment	Type	Sample Contents	Solvent	Ionic Strength	pH	Pressure	Temperature (K)	Spectrometer
1	2D NOESY	2-4mM Syndecan-4 cytoplasmic domain;Molar ratio of 4:1(syndecan-4 peptide:PIP2);50mM sodium phosphate;90% H2O 10% D2O	90% H2O/10% D2O	50mM sodium phosphate	7.4	1 atm	298
2	DQF-COSY	2-4mM Syndecan-4 cytoplasmic domain;Molar ratio of 4:1(syndecan-4 peptide:PIP2);50mM sodium phosphate;90% H2O 10% D2O	90% H2O/10% D2O	50mM sodium phosphate	7.4	1 atm	298
3	2D NOESY	2-4mM Syndecan-4 cytoplasmic domain;Molar ratio of 4:1(syndecan-4 peptide:PIP2);50mM sodium phosphate;90% H2O 10% D2O	100% D2O	50mM sodium phosphate	7.4	1 atm	298

NMR Spectrometer Information
Spectrometer	Manufacturer	Model	Field Strength
1	Bruker	DRX	500
2	Bruker	DRX	500
3	Bruker	DRX	500

NMR Refinement
Method	Details	Software
simulated annealing		XwinNMR

NMR Ensemble Information
Conformer Selection Criteria	structures with the lowest energy
Conformers Calculated Total Number	90
Conformers Submitted Total Number	15
Representative Model	1 (minimized average structure)

Additional NMR Experimental Information
Details	This structure was determined using standard 2D homonuclear techniques.

Computation: NMR Software
#	Classification	Version	Software Name	Author
1	collection	XwinNMR	2.5	Bruker
2	processing	XwinNMR	2.5	Bruker
3	data analysis	Sparky	3.6	James, T.
4	refinement	X-PLOR	3.851	Brunger, A.T

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.